Skip to main content

Find Clinical Trials

Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,828 public trials 827 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

NCT03067129

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Univ of California San Francis /ID# 158002 San Francisco, California, United States

Childrens Hospital Colorado /ID# 157996 Aurora, Colorado, United States

CT Childrens Medical Ctr, US /ID# 158639 Hartford, Connecticut, United States

UF Hepatology Research at CTRB /ID# 158008 Gainesville, Florida, United States

View all 38 locations

View Trial Details

Completed

Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)

NCT04530604

Conditions: Acute Respiratory Distress Syndrome, COVID, COVID-19, +14 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection

NCT05226416

Conditions: Anemia, Arrhythmias, Cardiac, Arrythmia, +74 more
Locations: Eurasian Association of Therapists Moscow, Russia

View Trial Details

Completed

Pharmacokinetics of Atazanavir in Special Populations

NCT03923231

Conditions: Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +20 more
Locations: Desmond Tutu HIV Foundation Cape Town, Western Cape, South Africa

University of Cape Town Cape Town, Western Cape, South Africa

Infectious Diseases Institute Kampala, Uganda

Joint Clinical Research Centre Kampala, Uganda

View Trial Details

Completed

Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients

NCT05062525

Conditions: COVID-19, Cancer, Coronaviridae Infections, +11 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

NCT04630015

Conditions: COVID-19, COVID-19 Infection, Coronaviridae Infections, +17 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire

NCT04534595

Conditions: Behavior, COVID-19, COVID-19 Experience, +13 more
Locations: Unity Health Toronto Toronto, Ontario, Canada

View Trial Details

Completed

Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS

NCT05786703

Conditions: Blood-Borne Infections, Cardiovascular Diseases, Communicable Diseases, +19 more
Locations: Temeke Regional Referral Hospital Dar es Salaam, Tanzania

View Trial Details

Completed

Biosound Therapy as a Treatment for Long COVID Patients

NCT05848401

Conditions: COVID-19, Chronic Disease, Coronaviridae Infections, +16 more
Locations: The Anxiety Relief Center Fishers, Indiana, United States

View Trial Details

Completed

Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection

NCT04753762

Conditions: COVID-19, COVID-19 Virus Disease, Cardiac Complication, +11 more
Locations: Laura FILIPPETTI Vandœuvre-lès-Nancy, France

View Trial Details